SCHEMBL2239611

SCHEMBL2239611

O=C(Nc1ccc(Cl)c(Cl)c1)C1CCCCC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.64
ALDH1A1 P00352 4/20 0.64
TSHR P16473 1/20 0.64
MEN1 O00255 4/20 0.63
KMT2A Q03164 4/20 0.63
SMN1; SMN2 Q16637 3/20 0.63
LMNA P02545 2/20 0.63
ALOX12 P18054 2/20 0.63
HTT P42858 2/20 0.63
ALOX15 P16050 1/20 0.63
PTPN1 P18031 1/20 0.63
NPC1 O15118 1/20 0.58
KDM4E B2RXH2 1/20 0.57
HSD17B10 Q99714 1/20 0.57
GRM4 Q14833 1/20 0.56
MAPT P10636 1/20 0.56
NPSR1 Q6W5P4 1/20 0.56
NPY2R P49146 1/20 0.56
EPHX1 P07099 1/20 0.56
EPHX2 P34913 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL134242 0.92 KMT2A (0.73) HPGDMEN1KMT2ASMN1; SMN2LMNA
SCHEMBL9706943 0.92 KMT2A (0.73) HPGDMEN1KMT2ASMN1; SMN2LMNA
SCHEMBL29462402 0.92 KMT2A (0.73) HPGDMEN1KMT2ASMN1; SMN2LMNA
SCHEMBL2241850 0.86 ALDH1A1 (0.60) HPGDALDH1A1TSHRMEN1KMT2A
SCHEMBL4096062 0.86 PTPN1 (0.58) HPGDALDH1A1TSHRMEN1KMT2A
SCHEMBL7522405 0.86 MEN1 (0.61) HPGDALDH1A1TSHRMEN1KMT2A
SCHEMBL2492827 0.85 HPGD (0.56) HPGDALDH1A1TSHRMEN1KMT2A
Hydrochloric Acid SCHEMBL1942210 0.84 MEN1 (0.60) HPGDALDH1A1TSHRMEN1KMT2A
SCHEMBL26279821 0.84 HPGD (0.61) HPGDALDH1A1TSHRMEN1KMT2A
SCHEMBL8278410 0.84 ALDH1A1 (0.60) HPGDALDH1A1TSHRMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230295088-A1 INSULIN SENSITIZERS FOR THE TREATMENT OF DIABETES MELLITUS UNIVERSITY OF IOWA RESEARCH FOUNDATION 2023-09-21 US disclosed
US-20230295088-A1 INSULIN SENSITIZERS FOR THE TREATMENT OF DIABETES MELLITUS UNIVERSITY OF IOWA RESEARCH FOUNDATION 2023-09-21 US disclosed
US-20110195979-A1 COMPOUNDS FOR THE TREATMENT AND PREVENTION OF INFLUENZA F. HOFFMANN-LA ROCHE AG (CH) 2011-08-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230295088-A1 INSULIN SENSITIZERS FOR THE TREATMENT OF DIABETES MELLITUS IAPP, GPR119, INSR HPGD 1451/4885ALDH1A1 3323/4885TSHR 609/4885
US-20110195979-A1 COMPOUNDS FOR THE TREATMENT AND PREVENTION OF INFLUENZA NAT1, NHERF1, ADORA1 HPGD 1896/4885ALDH1A1 507/4885TSHR 291/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.